Tickers — D

66 tickers
Sorts the reports on this page by score, highest first.
Digi International Inc.
DGII·Technology
A ★★★★Buy
Current$55.43
Target$63.00
Return+13.7%
Nov 14, 2026

Digi International offers expanding industrial IoT recurring revenue, improving margins, and an attractive valuation after its selloff, although slower organic growth and acquisition execution could constrain future returns.

Score
81
DHT Holdings, Inc.
DHT·Energy
B ★★★Hold
Current$21.57
Target$22.75
Return+5.5%
Nov 12, 2026

DHT combines exceptional VLCC freight earnings, disciplined fleet renewal, and substantial shareholder distributions, but its elevated asset valuation and sensitivity to shipping-cycle normalization constrain prospective returns.

Score
68
Definium Therapeutics, Inc.
DFTX·Healthcare
C ★★Sell
Current$34.47
Nov 12, 2026

Definium's positive Phase 3 psychiatry trials and substantial cash reserves create meaningful commercial potential, but significant dilution, pre-revenue losses, and unresolved regulatory and launch risks weaken its current investment case.

Score
57
Dyne Therapeutics, Inc.
DYN·Healthcare
D ★Strong Sell
Current$18.62
Nov 10, 2026

Dyne Therapeutics could establish valuable DMD and DM1 franchises through its differentiated FORCE platform, but pre-commercial losses, substantial dilution, and concentrated regulatory risks weaken the current investment case.

Score
47
Dianthus Therapeutics, Inc.
DNTH·Healthcare
F Avoid
Current$90.00
Nov 10, 2026

Dianthus Therapeutics offers meaningful upside through differentiated autoimmune therapies and a well-funded late-stage pipeline, but its high valuation, unproven commercial model, and substantial dilution create an unfavorable risk-reward profile.

Score
38
Amdocs Limited
DOX·Technology
C ★★Sell
Current$41.74
Nov 10, 2026

Amdocs offers historically inexpensive cash-generative telecom software assets and recovery potential through AI modernization, but the T-Mobile dispute and severe FY2027 earnings contraction undermine near-term investment confidence.

Score
59
Delek Logistics Partners, LP
DKL·Energy
C ★★Sell
Current$51.77
Nov 9, 2026

Delek Logistics offers high cash income and identifiable midstream growth opportunities, but its premium enterprise valuation, substantial leverage, and narrowing distribution coverage weaken the investment case.

Score
56
Delek US Holdings, Inc.
DK·Energy
B ★★★Hold
Current$63.95
Target$78.51
Return+22.8%
Nov 9, 2026

Delek US offers improving refinery cash flow and substantial logistics asset value, but volatile crack spreads, regulatory uncertainty, and uncertain through-cycle profitability constrain its investment appeal.

Score
66
Duke Energy Corporation
DUK·Utilities
B ★★★Hold
Current$127.78
Target$136.23
Return+6.6%
Nov 8, 2026

Duke Energy combines a durable regulated utility moat, growing electricity demand and dependable dividends, but its massive capital program, debt burden and persistent negative free cash flow limit near-term shareholder upside.

Score
71
DTE Energy Company
DTE·Utilities
B ★★★Hold
Current$135.08
Target$141.71
Return+4.9%
Nov 8, 2026

DTE Energy combines a durable regulated utility franchise, attractive dividends, and expanding data-center demand, but heavy capital spending, high leverage, and financing costs constrain its near-term risk-reward profile.

Score
70
DXP Enterprises, Inc.
DXPE·Industrials
B ★★★Hold
Current$140.68
Target$150.00
Return+6.6%
Nov 8, 2026

DXP combines specialized industrial distribution, pumping solutions, and acquisition-led growth with improving profitability, but leverage, cash-flow volatility, and an elevated historical valuation limit its margin of safety.

Score
73